Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Investigation of Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia for Diagnostic Procedures and Surgeries on or Through Accessible Mucous Membranes of the Nasal Cavities.

NCT01746940 is registered in ClinicalTrials.gov with Lannett Company, Inc. as lead sponsor.

NCT NCT01746940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01746940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Investigation of Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia for Diagnostic Procedures and Surgeries on or Through Accessible Mucous Membranes of the Nasal Cavities.
Lead sponsor
Lannett Company, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2014
Completion date
July 31, 2015
Enrollment
159 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diagnostic, of the nasal cavities, procedures and surgeries on or through accessible mucous membranes